Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Pavmed Inc (NQ: PAVM )

7.090 USD +0.240 (+3.50%)
Streaming Delayed Price Updated: 11:52 AM EDT, Jul 29, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,264,506
Open 6.850
Bid (Size) 7.080 (5)
Ask (Size) 7.090 (5)
Prev. Close 6.850
Today's Range 6.690 - 7.500
52wk Range 1.630 - 7.060
Shares Outstanding 83,869,061
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stanley Lapidus, Founder and Former Chairman & CEO of Exact Sciences, Joins PAVmed Subsidiary Lucid Diagnostics as Vice Chairman of its Board of Directors
Stanley Lapidus, former Chairman & CEO of Exact Sciences, joins PAVmed subsidiary Lucid Diagnostics as Vice Chairman of its Board of Directors. 
From Business Wire News Releases
PAVmed Subsidiary Lucid Diagnostics Launches Strategic Partnership with Direct-to-Consumer Telemedicine Company UpScriptHealth
PAVmed Subsidiary Lucid Diagnostics launches strategic partnership with direct-to-consumer telemedicine company UpScriptHealth. 
From Business Wire News Releases

Performance

YTD
+212.33%
+212.33%
1 Month
+7.26%
+7.26%
3 Month
+47.40%
+47.40%
6 Month
+247.55%
+247.55%
1 Year
+250.99%
+250.99%

More News

Read More
Tim Baxter, Former CEO of Samsung Electronics North America and Global Technology Industry Leader, Joins PAVmed Board of Directors
From GlobeNewswire News Releases
Angeles Equity Partners Appoints Debbie White to Xanitos Board of Directors
From Business Wire News Releases
Medrio Selected as Exclusive Data Management Solution for Leading Device and Diagnostic Sponsor
From PR Newswire
PAVmed Subsidiary Lucid Diagnostics Completes European CE Mark Certification of its EsoGuard Esophageal DNA Test
From GlobeNewswire News Releases
PAVmed Launches Digital Health Company Veris Health Inc.
From GlobeNewswire News Releases
PAVmed Subsidiary Lucid Diagnostics Receives CE Mark Certification for its EsoCheck® Esophageal Cell Collection Device
From GlobeNewswire News Releases
PAVmed Receives European CE Mark Certification for its CarpX® Minimally Invasive Carpal Tunnel Device
From GlobeNewswire News Releases
Data Presented at Digestive Disease Week 2021 Support Clinical Utility of PAVmed Subsidiary Lucid Diagnostics’ EsoCheck and EsoGuard Technologies
From GlobeNewswire News Releases
First Week of March 2022 Options Trading For PAVmed
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]